LifeMD
LFMD
About: LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Employees: 336
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
264% more capital invested
Capital invested by funds: $89.7M [Q1] → $326M (+$236M) [Q2]
128% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 18
113% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 24
83% more call options, than puts
Call options by funds: $17.3M | Put options by funds: $9.44M
23% more funds holding
Funds holding: 102 [Q1] → 125 (+23) [Q2]
15.69% more ownership
Funds ownership: 36.98% [Q1] → 52.67% (+15.69%) [Q2]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
|
HC Wainwright & Co.
Yi Chen
|
$13
|
Buy
Maintained
|
7 Aug 2025 |
|
Lake Street
Brooks O'Neil
|
$14
|
Buy
Maintained
|
6 Aug 2025 |
|
Keybanc
Scott Schoenhaus
|
$12
|
Overweight
Maintained
|
6 Aug 2025 |
|
Keybanc
Aleksey Yefremov
|
$14
|
Overweight
Maintained
|
14 Jul 2025 |
Financial journalist opinion
Based on 84 articles about LFMD published over the past 30 days
